mometasone
Changing the label
Pharmacists question proposed label and advisory changes for OTC mometasone preparations Both the Pharmacy Guild of Australia and the PSA had concerns over the proposed new advisory statements for labels …
Downscheduling welcomed
Downscheduling of migraine treatments begins on 1 Feb The Pharmacy Guild of Australia welcomed the confirmed decision to down-schedule the migraine treatments sumatriptan and zolmitriptan to S3, or pharmacist-only, medicines. …
Scheduling changes on the agenda
New proposals may see pharmacists dispensing downscheduled allergic rhinitis, migraine treatments, while caffeine powders are to be effectively banned The TGA’s medicine scheduling committee is set to rule on proposals …
Staying the same
Mometasone to remain a mostly prescription product after downscheduling application is knocked back TGA regulators have rejected a proposal to move the corticosteroid mometasone to become a Schedule 3 product. …